Diagnosing Sideroblastic Anemia: Key Tests and Interpretation

Sideroblastic anemias are a heterogeneous group of disorders characterized by defective heme synthesis, leading to mitochondrial iron accumulation in erythroblasts (ring sideroblasts). Diagnosis integrates peripheral blood, bone marrow, iron studies, and genetics.

Essential Diagnostic Tests

  • Complete Blood Count (CBC): Typically microcytic or dimorphic (mixed microcytic/normocytic) anemia; RDW often elevated.
  • Peripheral Smear: Dimorphic population—hypochromic microcytes + normocytes; basophilic stippling; Pappenheimer bodies (siderotic granules).
  • Iron Studies: High serum iron, high ferritin, high transferrin saturation (>50–80%), low/normal TIBC—pattern of iron overload despite anemia.
  • Bone Marrow Aspiration/Biopsy (Gold Standard): Prussian blue stain reveals ring sideroblasts (iron-laden mitochondria encircling ≥1/3 of erythroblast nucleus). ≥15% ring sideroblasts (WHO) or ≥5% (ICSH) confirms diagnosis.

Etiologic Workup

  • Acquired (Reversible): Alcohol, lead, zinc toxicity, drugs (isoniazid, chloramphenicol, linezolid), copper deficiency, myelodysplastic syndromes (MDS).
  • Congenital: X-linked (ALAS2), autosomal recessive (SLC25A38, GLRX5, ABCB7, PUS1), or mitochondrial (Pearson syndrome).
  • Genetic Testing: Targeted panel or exome sequencing for congenital forms; guides prognosis, inheritance counseling, and therapy (e.g., pyridoxine responsiveness in ALAS2).
  • Additional Studies

    • Lead level, zinc/copper, B6, alcohol history.
    • Liver function tests (hemosiderosis risk).
    • Erythropoietin level (often inappropriately low for degree of anemia in MDS).

    Diagnosis requires integration of morphology, iron parameters, marrow iron, and genetics. Reversible causes should be excluded before committing to lifelong classification.

    Blood Disorders - Related Articles